Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles-Reference-Cited by-同舟云学术

Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles

Published:2021-01-22 Issue:6 Volume:15 Page:9627-9637
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Elia Uri¹²³⁴⁵,Ramishetti Srinivas¹²³⁴,Rosenfeld Ronit⁵,Dammes Niels¹²³⁴,Bar-Haim Erez⁵,Naidu Gonna Somu¹²³⁴,Makdasi Efi⁶,Yahalom-Ronen Yfat⁶,Tamir Hadas⁶,Paran Nir⁶,Cohen Ofer⁵,Peer Dan¹²³⁴^ORCID

Affiliation:

1. Laboratory of Precision NanoMedicine, Shmunis School for Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel

2. Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv 69978, Israel

3. Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv 69978, Israel

4. Cancer Biology Research Center, Tel Aviv University, Tel Aviv 69978, Israel

5. Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 76100, Israel

6. Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona 76100, Israel

Funder

Lewis Trust

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.0c10180

Reference39 articles.

1. Coronavirus Disease (COVID-19), World Health Organization, Oct. 11, 2020; https://www.who.int/docs/default-source/coronaviruse/situation-reports/20201012-weekly-epi-update-9.pdf (accessed 2020-10-12).

2. Draft Landscape of COVID-19 Candidate Vaccines, World Health Organization; https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines (accessed 2020-10-02).

3. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

4. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

5. Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current landscape of mRNA technologies and delivery systems for new modality therapeutics;Journal of Biomedical Science;2024-09-10

2. Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication;DARU Journal of Pharmaceutical Sciences;2024-07-19

3. Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments;International Journal of Pharmaceutics;2024-07

4. Lipid nanoparticles-based RNA therapies for breast cancer treatment;Drug Delivery and Translational Research;2024-06-03

5. Transcription factor EHF interacting with coactivator AJUBA aggravates malignancy and acts as a therapeutic target for gastroesophageal adenocarcinoma;Acta Pharmaceutica Sinica B;2024-05